Theories of Etiopathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Biopsy, Needle
Breast Implantation
/ adverse effects
Breast Implants
/ adverse effects
Breast Neoplasms
/ epidemiology
Evidence-Based Medicine
Female
Follow-Up Studies
Humans
Immunohistochemistry
Lymphoma, Large-Cell, Anaplastic
/ epidemiology
Needs Assessment
Postoperative Complications
/ epidemiology
Risk Assessment
Sensitivity and Specificity
Seroma
/ etiology
Silicone Gels
/ adverse effects
Time Factors
Journal
Plastic and reconstructive surgery
ISSN: 1529-4242
Titre abrégé: Plast Reconstr Surg
Pays: United States
ID NLM: 1306050
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
entrez:
1
3
2019
pubmed:
1
3
2019
medline:
4
4
2019
Statut:
ppublish
Résumé
Breast implant-associated anaplastic large cell lymphoma is a malignancy of T lymphocytes that is associated with the use of textured breast implants in both esthetic and reconstructive surgeries. Patients typically present with a delayed seroma 8-10 years following implantation or-less commonly-with a capsular mass or systemic disease. Current theories on disease pathogenesis focus on the interplay among textured implants, Gram-negative bacteria, host genetics, and time. The possible roles of silicone leachables and particles have been less well substantiated. This review aims to synthesize the existing scientific evidence regarding breast implant-associated anaplastic large cell lymphoma etiopathogenesis.
Identifiants
pubmed: 30817553
doi: 10.1097/PRS.0000000000005566
pii: 00006534-201903001-00006
doi:
Substances chimiques
Silicone Gels
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
23S-29SRéférences
U.S. Food and Drug Administration. Anaplastic large cell lymphoma (ALCL) in women with breast implants: preliminary FDA findings and analyses. 2011. Silver Spring, MD: Center for Devices and Radiological Health; Available at: https://www.fda.gov/medicaldevices/productsandmedicalprocedures/implantsandprosthetics/breastimplants/ucm239995.htm. Accessed September 4, 2018.
Clemens MW, Miranda RNComing of age: breast implant-associated anaplastic large cell lymphoma after 18 years of investigation. Clin Plast Surg. 2015;42:605–613.
Clemens MWDiscussion: breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand: high-surface-area textured implants are associated with increased risk. Plast Reconstr Surg. 2017;140:660–662.
Loch-Wilkinson A, Beath KJ, Knight RJW, et al.Breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand: high-surface-area textured implants are associated with increased risk. Plast Reconstr Surg. 2017;140:645–654.
Clemens MW, Brody GS, Mahabir RC, et al.How to diagnose and treat breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg. 2018;141:586e–599e.
Clemens MW, Medeiros LJ, Butler CE, et al.Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma. J Clin Oncol. 2016;34:160–168.
Kadin ME, Deva A, Xu H, et al.Biomarkers provide clues to early events in the pathogenesis of breast implant-associated anaplastic large cell lymphoma. Aesthet Surg J. 2016;36:773–781.
Kadin ME, Morgan J, Xu H, et al.CD30+ T cells in late seroma may not be diagnostic of breast implant-associated anaplastic large cell lymphoma. Aesthet Surg J. 2017;37:771–775.
Doren EL, Miranda RN, Selber JC, et al.U.S. epidemiology of breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg. 2017;139:1042–1050.
Brody GS, Deapen D, Taylor CR, et al.Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases. Plast Reconstr Surg. 2015;135:695–705.
Clemens MW, Horwitz SMNCCN consensus guidelines for the diagnosis and management of breast implant-associated anaplastic large cell lymphoma. Aesthet Surg J. 2017;37:285–289.
Swerdlow SH, Campo E, Pileri SA, et al.The 2016 revision of the World Health Organization (WHO) classification of lymphoid neoplasms. Blood. 2016;127:2375–2390.
Oishi N, Brody GS, Ketterling RP, et al.Genetic subtyping of breast implant-associated anaplastic large cell lymphoma. Blood. 2018;132:544–547.
Prince HM, Johnstone RCommentary on: biomarkers provide clues to early events in the pathogenesis of breast implant-associated anaplastic large cell lymphoma. Aesthet Surg J. 2016;36:782–783.
Burg G, Kempf W, Haeffner A, et al.From inflammation to neoplasia: new concepts in the pathogenesis of cutaneous lymphomas. Recent Results Cancer Res. 2002;160:271–280.
Fleming D, Stone J, Tansley PSpontaneous regression and resolution of breast implant-associated anaplastic large cell lymphoma: implications for research, diagnosis and clinical management. Aesthetic Plast Surg. 2018;42:672–678.
Adams WP JrDiscussion: breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand: high-surface-area textured implants are associated with increased risk. Plast Reconstr Surg. 2017;140:663–665.
Pennock ND, White JT, Cross EW, et al.T cell responses: naive to memory and everything in between. Adv Physiol Educ. 2013;37:273–283.
Meresse B, Ripoche J, Heyman M, et al.Celiac disease: from oral tolerance to intestinal inflammation, autoimmunity and lymphomagenesis. Mucosal Immunol. 2009;2:8–23.
Rauch D, Gross S, Harding J, et al.T-cell activation promotes tumorigenesis in inflammation-associated cancer. Retrovirology. 2009;6:116.
Lechner MG, Megiel C, Church CH, et al.Survival signals and targets for therapy in breast implant-associated ALK-anaplastic large cell lymphoma. Clin Cancer Res. 2012;18:4549–4559.
Myint AA, Lee W, Mun S, et al.Influence of membrane surface properties on the behavior of initial bacterial adhesion and biofilm development onto nanofiltration membranes. Biofouling. 2010;26:313–321.
Teughels W, Van Assche N, Sliepen I, et al.Effect of material characteristics and/or surface topography on biofilm development. Clin Oral Implants Res. 2006;17(suppl 2):68–81.
Jacombs A, Tahir S, Hu H, et al.In vitro and in vivo investigation of the influence of implant surface on the formation of bacterial biofilm in mammary implants. Plast Reconstr Surg. 2014;133:471e–480e.
Ajdic D, Zoghbi Y, Gerth D, et al.The relationship of bacterial biofilms and capsular contracture in breast implants. Aesthet Surg J. 2016;36:297–309.
Hu H, Jacombs A, Vickery K, et al.Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: implications for breast implant-associated lymphoma. Plast Reconstr Surg. 2015;135:319–329.
Jones P, Mempin M, Hu H, et al.The functional influence of breast implant outer shell morphology on bacterial attachment and growth. Plast Reconstr Surg. 2018;142:837–849.
Hu H, Johani K, Almatroudi A, et al.Bacterial biofilm infection detected in breast implant-associated anaplastic large-cell lymphoma. Plast Reconstr Surg. 2016;137:1659–1669.
Mladick RASignificance of Staphylococcus epidermidis causing subclinical infection. Plast Reconstr Surg. 2005;115:1426–1427; author reply 1427.
Wong CH, Samuel M, Tan BK, et al.Capsular contracture in subglandular breast augmentation with textured versus smooth breast implants: a systematic review. Plast Reconstr Surg. 2006;118:1224–1236.
Ryan MP, Adley CCRalstonia spp.: emerging global opportunistic pathogens. Eur J Clin Microbiol Infect Dis. 2014;33:291–304.
Morrissey D, O’Sullivan GC, Tangney MTumour targeting with systemically administered bacteria. Curr Gene Ther. 2010;10:3–14.
Myckatyn TM, Parikh RPDiscussion: breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand: high-surface-area textured implants are associated with increased risk. Plast Reconstr Surg. 2017;140:655–658.
Munford RSSensing Gram-negative bacterial lipopolysaccharides: a human disease determinant? Infect Immun. 2008;76:454–465.
Jappe USuperantigens and their association with dermatological inflammatory disease: facts and hypotheses. Acta Derm Venereol. 2000;20:321–328.
Deva AK, Adams WP Jr, Vickery KThe role of bacterial biofilms in device-associated infection. Plast Reconstr Surg. 2013;132:1319–1328.
Moyer HR, Ghazi B, Saunders N, et al.Contamination in smooth gel breast implant placement: testing a funnel versus digital insertion technique in a cadaver model. Aesthet Surg J. 2012;32:194–199.
Chopra K, Gowda AU, McNichols CHL, et al.Antimicrobial prophylaxis practice patterns in breast augmentation: a national survey of current practice. Ann Plast Surg. 2017;78:629–632.
Blombery P, Thompson ER, Jones K, et al.Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma. Haematologica. 2016;101:e387–e390.
Lechner MG, Megiel C, Church CH, et al.Survival signals and targets for therapy in breast implant-associated ALK–anaplastic large cell lymphoma. Clin Cancer Res. 2012;18:4549–4559.
Crescenzo R, Abate F, Lasorsa E, et al.European T-Cell Lymphoma Study Group, T-Cell Project: Prospective Collection of Data in Patients with Peripheral T-Cell Lymphoma and the AIRC 5xMille Consortium “Genetics-Driven Targeted Management of Lymphoid Malignancies.” Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma. Cancer Cell. 2015;27:516–532.
Di Napoli A, Jain P, Duranti E, et al.Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A. Br J Haematol. 2018;180:741–744.
Letourneau A, Maerevoet M, Milowich D, et al.Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphoma. Virchows Arch. 2018;473:505–511.
Oishi N, Brody GS, Ketterling RP, et al.Genetic subtyping of breast implant-associated anaplastic large cell lymphoma. Blood. 2018;132:544–547.
Pastorello RG, D’Almeida Costa F, Osorio C, et al.Breast implant-associated anaplastic large cell lymphoma in a Li-FRAUMENI patient: a case report. Diagn Pathol. 2018;13:10.
Lee YS, Filie A, Arthur D, et al.Breast implant-associated anaplastic large cell lymphoma in a patient with Li-Fraumeni syndrome. Histopathology. 2015;67:925–927.
Brown MH, Shenker R, Silver SACohesive silicone gel breast implants in aesthetic and reconstructive breast surgery. Plast Reconstr Surg. 2005;116:768–779; discussion 780.
Nemec J, Swerdlow SH, Bazaz R, et al.B-Cell lymphoproliferative disorder of an ICD pocket: a diagnostic puzzle in an immunosuppressed patient. Pacing Clin Electrophysiol. 2008;31:769–771.
Hojo N, Yakushijin Y, Narumi H, et al.Non-Hodgkin’s lymphoma developing in a pacemaker pocket. Int J Hematol. 2003;77:387–390.
kaiser W, Biesenbach G, Stuby U, et al.Human adjuvant disease: remission of silicone induced autoimmune disease after explanation of breast augmentation. Ann Rheum Dis. 1990;49:937–938.
Yu LT, Latorre G, Marotta J, et al.In vitro measurement of silicone bleed from breast implants. Plast Reconstr Surg. 1996;97:756–764.
Wolfram D, Rabensteiner E, Grundtman C, et al.T regulatory cells and TH17 cells in peri-silicone implant capsular fibrosis. Plast Reconstr Surg. 2012;129:327e–337e.
Cappellano G, Ploner C, Lobenwein S, et al.Immuno phenotypic characterization of human T cells after in vitro exposure to different silicone breast implant surfaces. PLoS One. 2018;13:e0192108.